Daniel N. Swisher JR - Jun 10, 2025 Form 4 Insider Report for CORCEPT THERAPEUTICS INC (CORT)

Role
Director
Signature
/s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr.
Stock symbol
CORT
Transactions as of
Jun 10, 2025
Transactions value $
-$124,366
Form type
4
Date filed
6/12/2025, 08:42 PM
Previous filing
Jun 4, 2025
Next filing
Jul 14, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Swisher Daniel N JR Director C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY /s/ Joseph Douglas Lyon, as attorney-in-fact for Daniel N. Swisher, Jr. 2025-06-12 0001323113

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CORT Common Stock Options Exercise $31K +2.2K $14.08 2.2K Jun 10, 2025 Direct
transaction CORT Common Stock Sale -$155K -2.2K -100% $70.61 0 Jun 10, 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CORT Stock option (right to buy) Options Exercise $0 -2.2K -18.18% $0.00 9.9K Jun 10, 2025 Common Stock 2.2K $14.08 Direct F2
transaction CORT Stock option (right to buy) Award $0 +15K $0.00 15K Jun 10, 2025 Common Stock 15K $72.27 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction was made pursuant to a 10b5-1 plan adopted by the Reporting Person on August 1, 2024 in effect at the time of this transaction.
F2 Fully exercisable.
F3 Exercisable ratably in equal installments on each monthly anniversary of June 10, 2025 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

Remarks:

The power of attorney under which this form was signed is on file with the Commission.